September 28, 2016 7:34 PM ET

Healthcare Equipment and Supplies

Company Overview of Oxford Immunotec Global PLC

Company Overview

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for the management of immune-regulated conditions. Its development activities principally focus on the areas of chronic infections, transplantation, autoimmune and inflammatory disease, and immune-oncology. The company develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immunologically controlled diseases. It offers T-SPOT.TB test, a single-cell based method for identifying latent tuberculosis infection. The company markets its T-SPOT.TB te...

115D Innovation Drive

Milton Park

Abingdon,  OX14 4RZ

United Kingdom

Founded in 2002

313 Employees

Phone:

44 1235 442780

Fax:

44 1235 442781

Key Executives for Oxford Immunotec Global PLC

Chief Executive Officer and Director
Age: 42
Total Annual Compensation: $414.5K
Chief Operations Officer
Age: 54
Total Annual Compensation: $293.5K
Chief Commercial Officer
Age: 55
Total Annual Compensation: $334.0K
Compensation as of Fiscal Year 2015.

Oxford Immunotec Global PLC Key Developments

Oxford Immunotec Global PLC Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016; Revised Revenue Guidance for the Full Year 2016; Provides Revenue Guidance for the Third Quarter of 2016

Oxford Immunotec Global PLC reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company reported total revenue of $19.154 million compared to $14.252 million a year ago. Loss from operations was $7.335 million compared to $6.607 million a year ago. Loss before income taxes was $6.449 million compared to $7.293 million a year ago. Net loss was $6.446 million compared to $7.294 million a year ago. Basic and diluted net loss per share attributable to ordinary shareholders was $0.29 compared to $0.33 a year ago. LBITDA was $5.808 million compared to $6.791 million a year ago. Adjusted LBITDA was $5.292 million compared to $6.488 million a year ago. For the six months, the company reported total revenue of $36.264 million compared to $28.053 million a year ago. Loss from operations was $14.529 million compared to $13.128 million a year ago. Loss before income taxes was $13.463 million compared to $13.557 million a year ago. Net loss was $13.495 million compared to $13.605 million a year ago. Net loss per share attributable to ordinary shareholders was $0.60 compared to $0.64 a year ago. LBITDA was $12.224 million compared to $12.587 million a year ago. Adjusted LBITDA was $11.071 million compared to $11.518 million a year ago. The company expects to report full year 2016 revenue of between $82.5 million and $84.5 million as compared to prior guidance of between $79.5 million and $82.5 million. The company expects to report revenue of between $24.2 million and $25.0 million for the third quarter of 2016.

Oxford Immunotec Global PLC Presents at Baird 2016 Global Healthcare Conference, Sep-07-2016 02:35 PM

Oxford Immunotec Global PLC Presents at Baird 2016 Global Healthcare Conference, Sep-07-2016 02:35 PM. Venue: The New York Palace, 455 Madison Avenue, New York, New York, United States. Speakers: Richard M. Altieri, Chief Financial Officer.

Oxford Immunotec Global PLC to Report Q2, 2016 Results on Aug 02, 2016

Oxford Immunotec Global PLC announced that they will report Q2, 2016 results at 9:00 AM, GMT Standard Time on Aug 02, 2016

Similar Private Companies By Industry

Company Name Region
11 Health Limited Europe
A. Algeo Limited Europe
Abingdon Health Ltd. Europe
Accentus Medical Ltd. Europe
AccuNostics Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 23, 2016
IMUGEN, Inc.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oxford Immunotec Global PLC, please visit www.oxfordimmunotec.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.